Next Generation Labs Granted Australian Patent for the Use of TFN® Combinational R- and S-Isomer Synthetic Nicotine in Tobacco Cessation Products
"*
- "*
From its inception, Next Generation Labs has "committed itself to the development of synthetic nicotine technology that can be used in modern nicotine delivery products. - The Company first started producing bulk synthetic nicotine in 2014, at a time when there was no commercial availability of isolated R- and S-isomer nicotine.
- *S-isomer nicotine is the nicotine form that naturally occurs in tobacco and that is often processed into tobacco derived nicotine liquids, or used in pharmaceutical nicotine cessation products such as patches and gums.
- NGL's TFN products are manufactured under strict conditions to meet cGMP, USP and EU standards to achieve a level of 99.97% pure synthetic nicotine.